NCT00710801View on ClinicalTrials.gov

Assessment of Biomarkers for Recurrent HCV Infection Post-liver Transplantation

CompletedOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

May 31, 2005

Conditions
Hepatitis C Virus
Trial Locations (1)

T6G 2B7

University of Alberta Hospital, Edmonton

Sponsors

Collaborators (1)

Novartis
All Listed Sponsors
collaborator

Novartis

INDUSTRY

lead

University of Alberta

OTHER